The trademark application ABECMA was filed by Celgene Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 17, 2021, and it was registered by office on September 24, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 44 with following description of goods:
Collection and preservation of human biological tissue, blood and cells
Medical diagnostic services
Medical treatment services
Provision of information and data for diagnosis and medical treatment.